Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€84.93
16.05.13
€94.00
06.11.13
10.70%
06.11.13

Hiper99 
17.08.19 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€85.44
16.05.13
€90.50
05.08.13
5.93%
05.08.13

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
02.08.19 50%
buy
Merck KGaA

Start price
Target price
Perf. (%)
€59.65
15.05.13
€70.00
01.08.13
5.49%
01.08.13

gerihouse 
02.08.19 50%
buy
Novartis AG

Start price
Target price
Perf. (%)
€55.91
25.04.13
€65.00
22.11.13
6.76%
22.11.13

gerihouse 
02.08.19 50%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€67.17
08.02.13
€75.00
25.02.13
7.31%
25.02.13

tbackenh 
16.08.19 50%
buy
Roche Holding AG GS

Start price
Target price
Perf. (%)
€162.80
28.01.13
€225.00
27.06.14
40.51%
27.06.14

philagent 
14.08.19 50%
buy
Novartis AG

Start price
Target price
Perf. (%)
€47.42
23.09.12
€59.00
04.11.21
68.72%
08.12.20

HarleyDavidson 
14.08.19 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€51.73
14.06.12
€60.00
17.07.12
8.36%
17.07.12

gerihouse 
02.08.19 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.32
21.11.11
€50.00
21.05.12
18.82%
21.05.12

Subdi 
14.08.19 50%
buy
Merck KGaA

Start price
Target price
Perf. (%)
€32.63
10.08.11
€35.89
09.02.12
23.53%
09.02.12

DirectorDealer_Intensive 
04.09.19 50%
buy
Merck KGaA

Start price
Target price
Perf. (%)
€37.55
29.07.11
€41.31
30.01.12
4.66%
30.01.12

DirectorDealer 
04.09.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€14.68
27.07.11
€18.00
26.01.12
25.99%
26.01.12

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€33.39
24.07.11
€45.00
24.01.12
6.69%
24.01.12

Subdi 
14.08.19 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€56.70
20.02.11
€61.00
11.05.11
6.70%
11.05.11

Riccardo 
18.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€13.88
21.11.10
€22.50
23.05.11
4.14%
23.05.11

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Merck KGaA

Start price
Target price
Perf. (%)
€31.14
29.09.10
€34.50
29.03.11
1.54%
29.03.11

Vip1959 
15.08.19 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.54
21.06.10
€53.60
17.09.10
5.22%
17.09.10

Jutsch 
30.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€15.52
25.04.10
€22.29
25.10.10
-9.83%
25.10.10

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
ValueFreak 
05.08.19 50%
buy
Actelion Ltd

Start price
Target price
Perf. (%)
€38.89
13.01.10
€50.00
13.07.10
-22.12%
13.07.10

Vip1959 
15.08.19 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€19.18
27.05.09
€25.00
19.11.09
26.88%
19.11.09

Xetrakarl 
14.08.19 50%
buy
Celgene Corp.

Start price
Target price
Perf. (%)
€20.81
04.05.08
€22.00
18.09.08
6.80%
18.09.08

Riccardo 
18.08.19 50%
buy
Celgene Corp.

Start price
Target price
Perf. (%)
€25.01
23.10.07
€30.00
03.11.07
-11.26%
03.11.07

Riccardo 
18.08.19 50%
buy
Celgene Corp.

Start price
Target price
Perf. (%)
€26.00
13.10.07
€30.00
23.10.07
-5.83%
23.10.07

Riccardo 
18.08.19 50%